BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 17326057)

  • 21. Isolation and enrichment of urologic tumor cells in blood samples by a semi-automated CD45 depletion autoMACS protocol.
    Meye A; Bilkenroth U; Schmidt U; Füssel S; Robel K; Melchior AM; Blümke K; Pinkert D; Bartel F; Linne C; Taubert H; Wirth MP
    Int J Oncol; 2002 Sep; 21(3):521-30. PubMed ID: 12168095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of circulating tumor cells in advanced head and neck cancer using the CellSearch system.
    Nichols AC; Lowes LE; Szeto CC; Basmaji J; Dhaliwal S; Chapeskie C; Todorovic B; Read N; Venkatesan V; Hammond A; Palma DA; Winquist E; Ernst S; Fung K; Franklin JH; Yoo J; Koropatnick J; Mymryk JS; Barrett JW; Allan AL
    Head Neck; 2012 Oct; 34(10):1440-4. PubMed ID: 22076949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of circulating tumor cells in breast cancer patients utilizing multiparameter flow cytometry and assessment of the prognosis of patients in different CTCs levels.
    Hu Y; Fan L; Zheng J; Cui R; Liu W; He Y; Li X; Huang S
    Cytometry A; 2010 Mar; 77(3):213-9. PubMed ID: 20169594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunomagnetic quantification of circulating tumoral cells in patients with prostate cancer: clinical and pathological correlation.
    Resel Folkersma L; Olivier Gómez C; San José Manso L; Veganzones de Castro S; Galante Romo I; Vidaurreta Lázaro M; de la Orden GV; Arroyo Fernández M; Díaz Rubio E; Silmi Moyano A; Maestro de Las Casas MA
    Arch Esp Urol; 2010; 63(1):23-31. PubMed ID: 20157216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The molecular detection of circulating tumor cells in bladder cancer using telomerase activity.
    Soria JC; Morat L; Durdux C; Housset M; Cortez A; Blaise R; Sabatier L
    J Urol; 2002 Jan; 167(1):352-6. PubMed ID: 11743355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of transurethral resection and cystoprostatectomy on dissemination of epithelial cells in the circulation of patients with bladder cancer.
    Desgrandchamps F; Teren M; Dal Cortivo L; Marolleau JP; Bertheau P; Villette JM; Cortesse A; Teillac P; Le Duc A; Hamdy FC
    Br J Cancer; 1999 Nov; 81(5):832-4. PubMed ID: 10555753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system?
    Dawood S; Broglio K; Valero V; Reuben J; Handy B; Islam R; Jackson S; Hortobagyi GN; Fritsche H; Cristofanilli M
    Cancer; 2008 Nov; 113(9):2422-30. PubMed ID: 18785255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection and clinic implication of circulating tumor cell in patients with lung cancer].
    Mu XL; Li LY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):313-8. PubMed ID: 15266838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of usefulness of urinary nuclear matrix protein 22 (NMP22) in the detection of urothelial transitional cell carcinoma].
    Miyoshi Y; Matsuzaki J; Miura T
    Hinyokika Kiyo; 2001 Jun; 47(6):379-83. PubMed ID: 11496392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of circulating tumor cells in peripheral blood of patients with renal cell carcinoma correlates with prognosis.
    Bluemke K; Bilkenroth U; Meye A; Fuessel S; Lautenschlaeger C; Goebel S; Melchior A; Heynemann H; Fornara P; Taubert H
    Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2190-4. PubMed ID: 19661076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apoptosis of circulating tumor cells in prostate cancer patients.
    Larson CJ; Moreno JG; Pienta KJ; Gross S; Repollet M; O'hara SM; Russell T; Terstappen LW
    Cytometry A; 2004 Nov; 62(1):46-53. PubMed ID: 15472900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and evaluation of a colorimetric membrane-array method for the detection of circulating tumor cells in the peripheral blood of Taiwanese patients with colorectal cancer.
    Wang JY; Yeh CS; Chen YF; Wu CH; Hsieh JS; Huang TJ; Huang SY; Lin SR
    Int J Mol Med; 2006 May; 17(5):737-47. PubMed ID: 16596255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating tumor cells in peripheral blood samples from patients with increased serum prostate specific antigen: initial results in early prostate cancer.
    Davis JW; Nakanishi H; Kumar VS; Bhadkamkar VA; McCormack R; Fritsche HA; Handy B; Gornet T; Babaian RJ
    J Urol; 2008 Jun; 179(6):2187-91; discussion 2191. PubMed ID: 18423725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation of circulating tumor cells in patients with hepatocellular carcinoma using a novel cell separation strategy.
    Xu W; Cao L; Chen L; Li J; Zhang XF; Qian HH; Kang XY; Zhang Y; Liao J; Shi LH; Yang YF; Wu MC; Yin ZF
    Clin Cancer Res; 2011 Jun; 17(11):3783-93. PubMed ID: 21527564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients.
    Wong SC; Chan CM; Ma BB; Hui EP; Ng SS; Lai PB; Cheung MT; Lo ES; Chan AK; Lam MY; Au TC; Chan AT
    Clin Cancer Res; 2009 Feb; 15(3):1005-12. PubMed ID: 19188172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer.
    Vona G; Estepa L; Béroud C; Damotte D; Capron F; Nalpas B; Mineur A; Franco D; Lacour B; Pol S; Bréchot C; Paterlini-Bréchot P
    Hepatology; 2004 Mar; 39(3):792-7. PubMed ID: 14999698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined determination of plasma MMP2, MMP9, and TIMP1 improves the non-invasive detection of transitional cell carcinoma of the bladder.
    Staack A; Badendieck S; Schnorr D; Loening SA; Jung K
    BMC Urol; 2006 Aug; 6():19. PubMed ID: 16901349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.
    Mostert B; Kraan J; Bolt-de Vries J; van der Spoel P; Sieuwerts AM; Schutte M; Timmermans AM; Foekens R; Martens JW; Gratama JW; Foekens JA; Sleijfer S
    Breast Cancer Res Treat; 2011 May; 127(1):33-41. PubMed ID: 20379845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved method increases sensitivity for circulating hepatocellular carcinoma cells.
    Liu HY; Qian HH; Zhang XF; Li J; Yang X; Sun B; Ma JY; Chen L; Yin ZF
    World J Gastroenterol; 2015 Mar; 21(10):2918-25. PubMed ID: 25780289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.